Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fan Yao
Institutions:
Huazhong Agricultural University,
First Hospital of China Medical University
Observed institutions:
Huazhong Agricultural University,
First Hospital of China Medical University
ORCID:
0000-0001-8689-0291
Observed ORCID:
0000-0001-8689-0291
OpenAlex ID:
A5024455927
Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC
2026
·
Xin Xu
, Xin Chen
, et al.
·
Nature Communications
·
9
Neoadjuvant Anbenitamab and HB1801 in ERBB2 -Positive Breast Cancer: A Phase 3 Randomized Clinical Trial
2026
·
Junjie Li
, Tong Liu
, et al.
·
JAMA Oncology
·
2
PDF
Liproxstatin-1 improves functional recovery after acute spinal cord injury by inhibiting ferroptosis-induced inflammation
2026
·
Pan Lei
, Jiangtao Yu
, et al.
·
Molecular and Cellular Neuroscience
·
1
Mining TCGA to reveal immunotherapy-related genes for soft tissue sarcoma
2025
·
Ruixin Li
, Fan Yao
, et al.
·
Medicine
·
1
Sentinel lymph node biopsy using dye alone in patients with initial clinical N1 breast cancer receiving neoadjuvant therapy: A multicenter diagnostic trial (Northern Breast Cancer Collaboration Group NBCG‐002)
2026
·
Lei Zhang
, Ang Zheng
, et al.
·
Cancer
PDF
Palbociclib combined with aromatase inhibitors for the treatment of breast cancer
2023
·
Fan Yao
·
http://isrctn.com/
Pyrotinib as a novel irreversible tyrosine kinase inhibitor for locally advanced human epidermal growth factor receptor 2-positive breast cancer
2019
·
Feng Jin
, Fan Yao
·
http://isrctn.com/
Show more works
View as search
Works count:
7
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type